Dehydrojuncusol, a Natural Phenanthrene Compound Extracted from


Journal

Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724

Informations de publication

Date de publication:
15 05 2019
Historique:
received: 09 11 2018
accepted: 21 02 2019
pubmed: 8 3 2019
medline: 3 3 2020
entrez: 8 3 2019
Statut: epublish

Résumé

Recent emergence of direct-acting antivirals (DAAs) targeting hepatitis C virus (HCV) proteins has considerably enhanced the success of antiviral therapy. However, the appearance of DAA-resistant-associated variants is a cause of treatment failure, and the high cost of DAAs renders the therapy not accessible in countries with inadequate medical infrastructures. Therefore, the search for new inhibitors with a lower cost of production should be pursued. In this context, the crude extract of

Identifiants

pubmed: 30842319
pii: JVI.02009-18
doi: 10.1128/JVI.02009-18
pmc: PMC6498043
pii:
doi:

Substances chimiques

Antiviral Agents 0
Phenanthrenes 0
Phenethylamines 0
Plant Extracts 0
Protease Inhibitors 0
N,N-dimethylphenylethylamine 1126-71-2
phenanthrene 448J8E5BST

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2019 American Society for Microbiology.

Références

Crit Rev Biotechnol. 2012 Dec;32(4):289-326
pubmed: 22129270
Phytochemistry. 2002 Jul;60(6):633-8
pubmed: 12126711
Nat Prod Rep. 2012 Sep;29(9):1007-21
pubmed: 22786554
J Pharm Pharmacol. 2017 Aug;69(8):1041-1055
pubmed: 28444868
Phytochemistry. 2008 Mar;69(5):1084-110
pubmed: 18243254
Proc Natl Acad Sci U S A. 2012 Nov 27;109(48):19757-62
pubmed: 23151512
J Virol. 2010 Jan;84(2):773-87
pubmed: 19906930
Antivir Ther. 2013;18(2):141-7
pubmed: 23011959
J Virol. 2015 Oct;89(19):10053-63
pubmed: 26202241
Molecules. 2018 Aug 20;23(8):
pubmed: 30127296
J Virol. 2011 Jul;85(14):7312-20
pubmed: 21593143
J Nat Prod. 2016 Mar 25;79(3):629-61
pubmed: 26852623
J Gen Virol. 1991 May;72 ( Pt 5):1195-8
pubmed: 1851819
J Virol. 2004 Jul;78(14):7400-9
pubmed: 15220413
Hepatology. 2011 Dec;54(6):1947-55
pubmed: 21837753
Antimicrob Agents Chemother. 2010 Aug;54(8):3187-96
pubmed: 20516278
J Med Virol. 2007 Feb;79(2):155-60
pubmed: 17177304
Lancet Gastroenterol Hepatol. 2017 Mar;2(3):161-176
pubmed: 28404132
Hepatology. 2011 Dec;54(6):1924-35
pubmed: 21809362
J Chemother. 1991 Oct;3(5):305-9
pubmed: 1667189
J Nat Prod. 2012 Mar 23;75(3):311-35
pubmed: 22316239
Oncogene. 2006 Jun 26;25(27):3834-47
pubmed: 16799625
J Clin Virol. 2004 Nov;31(3):227-34
pubmed: 15465417
Viruses. 2015 Jul 17;7(7):3995-4046
pubmed: 26193307
Gastroenterology. 2014 May;146(5):1176-92
pubmed: 24631495
Antiviral Res. 2015 Jul;119:89-96
pubmed: 25615583
Gastroenterology. 2016 Jul;151(1):70-86
pubmed: 27080301
J Gen Virol. 2007 Sep;88(Pt 9):2495-2503
pubmed: 17698659
Gastroenterology. 2016 Nov;151(5):973-985.e2
pubmed: 27453546
J Virol. 2002 Jun;76(12):5974-84
pubmed: 12021330
Gastroenterology. 2003 Dec;125(6):1808-17
pubmed: 14724833
J Hepatol. 2016 Feb;64(2):486-504
pubmed: 26409317
J Virol. 1994 Oct;68(10):6147-60
pubmed: 8083956
Nat Prod Res. 2012;26(13):1234-9
pubmed: 22017742
Gastroenterology. 2010 Oct;139(4):1355-64
pubmed: 20600021
Chem Pharm Bull (Tokyo). 2007 Aug;55(8):1264-6
pubmed: 17666857
Nat Prod Rep. 2004 Apr;21(2):263-77
pubmed: 15042149
Nat Rev Gastroenterol Hepatol. 2013 Sep;10(9):553-62
pubmed: 23817321
J Exp Med. 2003 Mar 3;197(5):633-42
pubmed: 12615904
Viruses. 2012 Oct 17;4(10):2197-217
pubmed: 23202460
J Virol. 2006 Mar;80(6):2832-41
pubmed: 16501092
Hepatology. 2012 Mar;55(3):720-9
pubmed: 22105803
J Virol. 2005 Aug;79(16):10826-9
pubmed: 16051874
Sci Rep. 2014 Apr 23;4:4765
pubmed: 24755925
J Viral Hepat. 2009 Oct;16(10):705-15
pubmed: 19281487
Hepatology. 2015 Jan;61(1):77-87
pubmed: 25069599
Hepatology. 2015 Nov;62(5):1623-32
pubmed: 26095927
Antimicrob Agents Chemother. 2015 Feb;59(2):979-87
pubmed: 25451055
J Virol. 2019 May 1;93(10):
pubmed: 30842319

Auteurs

Marie-Emmanuelle Sahuc (ME)

Center for Infection and Immunity of Lille (CIIL), University of Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019, UMR 8204, Lille, France.

Ramla Sahli (R)

Institut Charles Viollette (ICV), University of Lille, INRA, ISA, University Artois, Université du Littoral Côte d'Opale, EA 7394, Lille, France.
Laboratory of Aromatic and Medicinal Plants, Biotechnology Centre of Borj-Cédria (CBBC), Hammam-lif, Tunisia.

Céline Rivière (C)

Institut Charles Viollette (ICV), University of Lille, INRA, ISA, University Artois, Université du Littoral Côte d'Opale, EA 7394, Lille, France.

Véronique Pène (V)

University Paris Descartes, EA4474 "Hepatitis C Virology," Paris, France.

Muriel Lavie (M)

Center for Infection and Immunity of Lille (CIIL), University of Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019, UMR 8204, Lille, France.

Alexandre Vandeputte (A)

Center for Infection and Immunity of Lille (CIIL), University of Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019, UMR 8204, Lille, France.

Priscille Brodin (P)

Center for Infection and Immunity of Lille (CIIL), University of Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019, UMR 8204, Lille, France.

Arielle R Rosenberg (AR)

University Paris Descartes, EA4474 "Hepatitis C Virology," Paris, France.

Jean Dubuisson (J)

Center for Infection and Immunity of Lille (CIIL), University of Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019, UMR 8204, Lille, France.

Riadh Ksouri (R)

Laboratory of Aromatic and Medicinal Plants, Biotechnology Centre of Borj-Cédria (CBBC), Hammam-lif, Tunisia.

Yves Rouillé (Y)

Center for Infection and Immunity of Lille (CIIL), University of Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019, UMR 8204, Lille, France.

Sevser Sahpaz (S)

Institut Charles Viollette (ICV), University of Lille, INRA, ISA, University Artois, Université du Littoral Côte d'Opale, EA 7394, Lille, France.

Karin Séron (K)

Center for Infection and Immunity of Lille (CIIL), University of Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019, UMR 8204, Lille, France karin.seron@ibl.cnrs.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH